exRNAdisease

Entry Detail

---



General Information

Database ID: exR0728658 RNA Name: hsa-miR-185-5p RNA Type: miRNA Chromosome: chr22 Starnd: + Coordinate: Start Site(bp): 20033153 End Site(bp): 20033174 External Links: hsa-miR-185-5p

Disease Information

Disease Name: Prostate Cancer Disease Category: Cancers MeSH ID: D011471 Type: Neoplasms/Digestive System Neoplasms Alias: Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate

Expression Detail

GEO ID: GSE54010 Description: miRNA expression profiles in the 19 candidate urines (prostate cancer, CaP, patients and non-cancer subjects with benign prostatic hyperplasia, BPH) Experimental Design: Cancer vs Control Case Disease Type: Prostate Cancer Case Disease SubType: Advanced Prostate Cancer Case Sample: Advanced Prostate Cancer Control Sample: Benign Prostatic Hyperplasia Number of Case: 7 Number of Control: 5 Number of Samples: 12

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand TFAP2A chr6 10393186 10419659 - SSH2 chr17 29625938 29930276 - ZBTB4 chr17 7459366 7484263 - CTSA chr20 45890144 45898820 + TSPAN14 chr10 80454166 80533124 + ACVR1B chr12 51951699 51997078 + GRB2 chr17 75318076 75405709 - RAB5A chr3 19947097 19985175 + RAB40C chr16 589357 629272 + VPS37B chr12 122865330 122896127 - SLC29A1 chr6 44219553 44234142 + NDRG1 chr8 133237171 133302022 - HDLBP chr2 241227264 241317061 - RSU1 chr10 16590611 16817463 - HADHA chr2 26190635 26244672 - VPS4A chr16 69311350 69326939 + IGF2BP1 chr17 48997385 49056145 + NF1 chr17 31094927 31382116 + SMAD3 chr15 67063763 67195169 + ORAI1 chr12 121626550 121642677 + ADGRG1 chr16 57610652 57665580 + TNRC6B chr22 40044817 40335808 + ZMIZ1 chr10 79068966 79316528 + GOLGA1 chr9 124878275 124948492 - ZBTB38 chr3 141324213 141449792 + SLC29A2 chr11 66362521 66372214 - GATAD2B chr1 153789030 153923360 - GBA2 chr9 35736866 35749228 - OTUD4 chr4 145110838 145180589 - FAM234A chr16 234521 272183 + miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0001658 chr6 157357968 157406039 + hsa_circ_0000711 chr16 68155889 68160513 + hsa_circ_0001168 chr20 47691321 47707559 + hsa_circ_0001146 chr20 34241449 34246936 - hsa_circ_0001164 chr20 45891031 45923523 - lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC007952.4 chr17 19112000 19112636 - AC008040.1 chr3 169939353 169966734 - AC021092.1 chr19 44103007 44113183 - LINC01278 chrX 63222993 63561095 - MALAT1 chr11 65497688 65506516 + MIR137HG chr1 97933474 98049863 - MIR663AHG chr20 26167817 26251546 - NEAT1 chr11 65422774 65445540 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE54010 Sample Source: Urine Source Fraction: Urine Platform: GPL15159 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1183 Sample treatment protocol: NA RNA Extract protocol: Total RNA was extracted using RecoverAllTM Total Nucleic Acid Isolation kit (Life Technologies, Carlsbad, CA). RNA library preparation protocol: 400 ng of total RNA was labeled with cyanine 3-pCp using the Agilent miRNA Complete Labeling kit and hybridized to the array according to the manufacturer's protocol.

Reference

PMID: NA Title: NA Author: NA Journal: NA Description: NA